"Schedule I Accuser Faces Review Bombing Over Copyright Claims"

In the world of gaming, accusations of copyright infringement can stir up quite the storm. Recently, indie game Schedule I found itself at the center of such a controversy, accused by Movie Games S.A., the developers behind the The Drug Dealer Simulator series. This accusation, detailed by the Polish Press Agency on April 3, suggests that Schedule I might have borrowed the plot, mechanics, and user interface from The Drug Dealer Simulator games. However, despite the ongoing investigation, the gaming community's response has taken an unexpected turn.

Schedule I’s Copyright Infringement Accuser Gets Review Bombed on Steam

In a twist of events, fans have rallied behind Schedule I, leading to a significant backlash against Movie Games S.A. Both The Drug Dealer Simulator and Drug Dealer Simulator 2 have been hit with a wave of negative reviews on Steam, now labeled as "Overwhelmingly Negative" and "Mostly Negative," respectively. The reviews focus on Movie Games S.A.'s perceived bullying and accusations of hypocrisy, pointing out that similar games were not targeted until Schedule I hit the scene.

Despite this controversy, Schedule I continues to thrive. Released into Early Access on PC on March 25, this co-op crime simulation game has players starting as small-time dope pushers and climbing their way to become kingpins. The game has earned "Overwhelmingly Positive" reviews on Steam and has become the platform's 2nd top-selling game, surpassing titles like inZOI, Monster Hunter Wilds, and the indie-developed R.E.P.O. With an all-time peak of 459,075 concurrent players, according to SteamDB, Schedule I is clearly resonating with gamers.

At Game8, we found Schedule I to be a surprisingly addictive and rewarding experience, earning it the nickname "Breaking Bad" simulator. For a deeper dive into our thoughts on Schedule I's early access release, be sure to check out our detailed article below!